Home » Cabometyx® (Cabozantinib) now available for eligible patients with non-clear cell renal cell carcinoma via the PBS – News Hub

Cabometyx® (Cabozantinib) now available for eligible patients with non-clear cell renal cell carcinoma via the PBS – News Hub

by News Hub - Medianet News Hub archive | Sep 1, 2024 | Articles | 0 Comments